TY - JOUR
T1 - Relation of prescription nonsteroidal antiinflammatory drug use to cognitive function among community-dwelling elderly
AU - Hanlon, Joseph T.
AU - Schmader, Kenneth E.
AU - Landerman, Lawrence R.
AU - Horner, Ronnie D.
AU - Fillenbaum, Gerda G.
AU - Pieper, Carl F.
AU - Wall, William E.
AU - Koronkowski, Michael J.
AU - Cohen, Harvey Jay
N1 - Funding Information:
Thi\ work was supported by a grant from the Agency for Health Care Pohcy Research (R01-HS0781Y), an Academic Award to Dr. Schmader from the Nation11 Institute on Aging (AG00526), and by a grant from the (Xaude D. Pepper Older Americans Independence Center (P60A-GI 1268) to Drs. Cohen, Homer, Pieper, and Schmader. The dam upon which thiy publication was based were obtained pursuant to contract no. NO I -A(>-1-21 02 with the National Institute on Aging in support of the Esmhlished I’rpuiations for Epidemiologic Studies of the Elderly (Duke L Inrvcr\ir\ I.
PY - 1997/2
Y1 - 1997/2
N2 - To evaluate the relationship of nonsteroidal antiinflammatory drug (NSAID) use to level of cognitive function in community-dwelling elderly persons. METHODS: The prospective cohort study included 2765 nonproxy subjects from the Duke University Established Populations for Epidemiologic Studies of the Elderly who were cognitively intact at baseline (1986-1987) and alive at follow-up three year later. Cognitive function was assessed by the Short Portable Mental Status Questionnaire (i.e., intact vs. impaired and change in score) and by the individual domains of the Orientation-Memory- Concentration Test (i.e., number of errors). NSAID use, determined from in- home interviews, was coded for chronicity, dose, frequency of rise, and prescription status. RESULTS: After controlling for demographic factors as well as health status and behavior, continuous, regularly-scheduled, prescription use of NSAID was associated with preservation of one aspect of cognitive functioning: concentration (beta coefficient, 0.29; 95% confidence interval [CI] -0.54 to -0.04, indicating fewer errors). However, no consistent dose-response relationship was found. Current and prior NSAID use was unrelated to level of cognitive functioning across all five measures; among current users, those taking moderate or high doses (beta coefficient, 0.41; 95% CI, 0.08 to 0.74) made more errors on the memory test compared with those taking low doses (beta coefficient 0.03; 95% CI, -.85 to 0.91). CONCLUSIONS: These results suggest no substantial or consistent protective effect of prescription NSAID use on cognitive function in community-dwelling elderly. However, recent use at higher doses may be associated with memory deterioration in this population.
AB - To evaluate the relationship of nonsteroidal antiinflammatory drug (NSAID) use to level of cognitive function in community-dwelling elderly persons. METHODS: The prospective cohort study included 2765 nonproxy subjects from the Duke University Established Populations for Epidemiologic Studies of the Elderly who were cognitively intact at baseline (1986-1987) and alive at follow-up three year later. Cognitive function was assessed by the Short Portable Mental Status Questionnaire (i.e., intact vs. impaired and change in score) and by the individual domains of the Orientation-Memory- Concentration Test (i.e., number of errors). NSAID use, determined from in- home interviews, was coded for chronicity, dose, frequency of rise, and prescription status. RESULTS: After controlling for demographic factors as well as health status and behavior, continuous, regularly-scheduled, prescription use of NSAID was associated with preservation of one aspect of cognitive functioning: concentration (beta coefficient, 0.29; 95% confidence interval [CI] -0.54 to -0.04, indicating fewer errors). However, no consistent dose-response relationship was found. Current and prior NSAID use was unrelated to level of cognitive functioning across all five measures; among current users, those taking moderate or high doses (beta coefficient, 0.41; 95% CI, 0.08 to 0.74) made more errors on the memory test compared with those taking low doses (beta coefficient 0.03; 95% CI, -.85 to 0.91). CONCLUSIONS: These results suggest no substantial or consistent protective effect of prescription NSAID use on cognitive function in community-dwelling elderly. However, recent use at higher doses may be associated with memory deterioration in this population.
KW - Nonsteroidal
KW - aged
KW - antiinflammatory agents
KW - cognition
KW - cohort studies
KW - memory
UR - http://www.scopus.com/inward/record.url?scp=0030903706&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030903706&partnerID=8YFLogxK
U2 - 10.1016/S1047-2797(96)00124-X
DO - 10.1016/S1047-2797(96)00124-X
M3 - Article
C2 - 9099396
AN - SCOPUS:0030903706
SN - 1047-2797
VL - 7
SP - 87
EP - 94
JO - Annals of Epidemiology
JF - Annals of Epidemiology
IS - 2
ER -